文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症COVID-19急性低氧血症患者入住ICU后的无创氧疗支持:一项多中心回顾性观察研究

Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study.
PubMed 文献 · Crit Care · 2022-02-08
一句话结论在重症COVID-19 ICU患者中,经鼻高流量氧疗与较低的气管插管率和ICU死亡率相关,作者认为其可能作为首选的无创氧疗支持策略。

该多中心回顾性观察研究纳入西班牙加泰罗尼亚26个ICU在2020年3月14日至4月15日期间收治的、入ICU时接受>10 L补充氧气的重症COVID-19患者,比较氧疗面罩、经鼻高流量氧疗和无创机械通气三种独立无创氧疗策略的临床结局。1093例非侵入性氧疗患者中,897例(82%)需要气管插管,310例(28%)在ICU期间死亡。经鼻高流量氧疗(n=439)和无创机械通气(n=101)的气管插管率分别为70%和88%,均低于氧疗面罩(n=553,插管率91%),p<0.001。与氧疗面罩相比,经鼻高流量氧疗与较低的ICU死亡率相关(HR 0.75,95%CI 0.58-0.98),无创机械通气的ICU死亡率HR为1.21(95%CI 0.80-1.83)。作者认为在缺乏确定性数据的情况下,经鼻高流量氧疗可能作为首选的无创氧疗支持策略。

要点

  • 1093例接受无创氧疗的重症COVID-19患者中,897例(82%)需要气管插管,310例(28%)在ICU期间死亡。
  • 经鼻高流量氧疗(n=439)气管插管率70%,无创机械通气(n=101)为88%,均低于氧疗面罩(n=553,91%),p<0.001。
  • 与氧疗面罩相比,经鼻高流量氧疗与较低的ICU死亡率相关(HR 0.75,95%CI 0.58-0.98)。
  • 与氧疗面罩相比,无创机械通气的ICU死亡率HR为1.21(95%CI 0.80-1.83)。
  • 作者认为,在缺乏确定性数据的情况下,经鼻高流量氧疗可能作为重症COVID-19 ICU患者首选的无创氧疗支持策略。

适用人群与场景

  • 西班牙加泰罗尼亚26个参与ICU在2020年3月14日至4月15日期间收治的重症COVID-19患者,入ICU时接受>10 L补充氧气并以氧疗面罩、经鼻高流量氧疗或无创机械通气之一作为独立无创氧疗策略。

研究设计与关键结果

  • 研究类型:多中心回顾性观察研究,26个参与ICU,纳入1093例入ICU时接受>10 L补充氧气的非侵入性氧疗重症COVID-19患者。
  • 主要结局:897例(82%)需要气管插管,310例(28%)在ICU期间死亡。
  • 经鼻高流量氧疗(n=439)气管插管率70%,无创机械通气(n=101)为88%,氧疗面罩(n=553)为91%,p<0.001。
  • 与氧疗面罩相比,经鼻高流量氧疗的ICU死亡率HR 0.75(95%CI 0.58-0.98);无创机械通气的ICU死亡率HR 1.21(95%CI 0.80-1.83)。
  • 研究采用九种协变量平衡算法中的最优算法对所有基线协变量进行平衡。

证据类型、等级与局限

  • 证据类型:多中心回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在缺乏确定性数据的情况下,经鼻高流量氧疗可能作为重症COVID-19 ICU患者首选的无创氧疗支持策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Non-invasive oxygenation strategies have a prominent role in the treatment of acute hypoxemic respiratory failure during the coronavirus disease 2019 (COVID-19). While the efficacy of these therapies has been studied in hospitalized patients with COVID-19, the clinical outcomes associated with oxygen masks, high-flow oxygen therapy by nasal cannula and non-invasive mechanical ventilation in critically ill intensive care unit (ICU) patients remain unclear.

METHODS: In this retrospective study, we used the best of nine covariate balancing algorithms on all baseline covariates in critically ill COVID-19 patients supported with > 10 L of supplemental oxygen at one of the 26 participating ICUs in Catalonia, Spain, between March 14 and April 15, 2020.

RESULTS: Of the 1093 non-invasively oxygenated patients at ICU admission treated with one of the three stand-alone non-invasive oxygenation strategies, 897 (82%) required endotracheal intubation and 310 (28%) died during the ICU stay. High-flow oxygen therapy by nasal cannula (n = 439) and non-invasive mechanical ventilation (n = 101) were associated with a lower rate of endotracheal intubation (70% and 88%, respectively) than oxygen masks (n = 553 and 91% intubated), p < 0.001. Compared to oxygen masks, high-flow oxygen therapy by nasal cannula was associated with lower ICU mortality (hazard ratio 0.75 [95% CI 0.58-0.98), and the hazard ratio for ICU mortality was 1.21 [95% CI 0.80-1.83] for non-invasive mechanical ventilation.

CONCLUSION: In critically ill COVID-19 ICU patients and, in the absence of conclusive data, high-flow oxygen therapy by nasal cannula may be the approach of choice as the primary non-invasive oxygenation support strategy.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Wendel-Garcia PD, Mas A, González-Isern C, et al. Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study. Crit Care. 2022. PMID: 35135588. doi:10.1186/s13054-022-03905-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。